Funding via a licensing deal means existing shareholders won't get diluted. If MB decides to raise funds for the trials, I don't think most shareholders will get the opportunity to participate, it will be done via institutional placements which will effectively dilute the holdings. If anyone wants to top up, I imagine they will get an opportunity to do so on market. The trials will take a while.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Completes Successful FDA and EMA Meetings for Phase 3
Ann: Opthea Completes Successful FDA and EMA Meetings for Phase 3, page-8
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
43.0¢ |
Change
0.015(3.61%) |
Mkt cap ! $529.3M |
Open | High | Low | Value | Volume |
42.0¢ | 44.0¢ | 40.5¢ | $679.0K | 1.610M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2499 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 61452 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2499 | 0.430 |
3 | 133334 | 0.425 |
4 | 56452 | 0.420 |
3 | 82179 | 0.415 |
7 | 130758 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 61452 | 2 |
0.445 | 117935 | 6 |
0.450 | 100418 | 3 |
0.455 | 46000 | 2 |
0.460 | 130000 | 3 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online